Pharmaceutical Contract Sales Outsourcing (CSO) Market By Sales Model (Dedicated Sales Model, Syndicate Sales Model); By Service Type (Personal Promotion (Sales Force Deployment, Vacancy Management, Others (Key Account Management, Physician Education Services, Etc.), Non-personal Promotion (Telesales, Medical Call Centers, Online Marketing and Sales, E-Sampling, others), Field Management, Distribution services, Products registration , Training and development, Targeting, Access and Reimbursement, Others (Recruiting, Sales Training, Etc.)); By Therapeutic Area (Cardiovascular Disorders, Oncology, Covid-19, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, Others); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
Large pharmaceutical corporations are seeking for medicines that can hit the market rapidly and at a low cost. For years, new speciality pharmaceutical businesses have looked for collaborations with established pharmaceutical corporations to help them get their brands to market. Despite promises to the contrary, the sales staff falls short of expectations. As a result, more and more pharmaceutical companies are turning towards contract sales outsourcing (CSO) services to bring about greater flexibility into their sales model. Emerging companies are looking forward to build an agile, scalable, responsive team to meet customer needs with the help of an experienced CSO partner, ensuring that critical market segments are catered to with the requisite type of sales representatives and scaling up and down as the market dictates, having no impact on their own operations. The growing need amongst pharmaceutical companies to encompass a larger market share is significantly driving the growth of pharmaceutical contract sales outsourcing (CSO) market.
CSOs have changed since their inception in the 1980s to match shifting market realities. CSOs now provide a comprehensive commercialization package in addition to various types and sizes of sales teams. There are several methods to work with big pharma companies, just as there are numerous ways to hire a CSO to get control over the brand's commercialization. Market analysis, targeting, and state and national payer access and reimbursement are all areas where CSOs have built competence. They also give access to health care providers through call centres and digital platforms, with built-in reporting to keep programmes on track. Furthermore, because CSOs have the benefit of working with businesses in a variety of sectors, their perspectives are based on a broad range of expertise, which showcases possibility to enhance overall engagement for the end users.
The prevalence of Covid-19 pandemic has had a massive impact on the overall pharmaceutical industry, driving a substantial portion of the operations to digital platforms. Pharmaceutical contract sales outsourcing (CSO) market participants are adapting digital models to better cater to the changing requirement of pharmaceutical manufacturers, which thus projects positive growth prospects for global pharmaceutical contract sales outsourcing (CSO) market over the forecast period.
In terms of revenue, pharmaceutical contract sales outsourcing (CSO) market was valued at US$ 6,954.74 Mn in 2020 growing at a CAGR of 8.7% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue & Forecast, (US$ Million), 2015 – 2029
Sales Model Outlook:
Based on sales model, the global pharmaceutical contract sales outsourcing (CSO) market is segmented into dedicated sales model and syndicate sales model. Syndicate sales model held the highest share in 2020. Syndicate sales models has been prevalent for a long time as companies initially invested lump sum amounts for marketing and promotions. Syndicate sales model involve sales managers along with medical representatives’ team working with the products of different manufacturer and not competing between themselves. As some companies are now looking out for short term contract sales outsourcing, they prefer syndicate sales model for their product launches particularly suited to seasonal products as anti-infectives.
Service Type Outlook:
Non-personal promotion segment is estimated to witness fastest growth over the forecast period. This segment includes telesales, medical call centres, online marketing and sales, e-sampling and others. Due to less access to doctors in their office, pharmaceutical contract sales outsourcing (CSO) companies are increasing their spending on digital tactics. Email, native advertisements, website promotion and social media advertising are amongst some of the strategies that have been used. The pharmaceutical contract sales outsourcing (CSO) market participants are devising their strategies that function on a target-by-target basis rather than releasing vast waves of general messages via non-personal promotion. Pharma CSO companies are developing a range of ways to interact to sales representative through non-personal promotion methods such as a scheduled phone calls and video conversations or social media platform channels, which is created for the respective brand and promoted on branded communication. Thus, pharmaceutical marketers are being increasingly creative with their non-personal promotional tactics, thereby enabling pharma companies to generate higher sales.
Therapeutic Outlook:
The therapeutic segment in the global pharmaceutical contract sales outsourcing (CSO) market is segmented into cardiovascular disorders, oncology, covid-19, metabolic disorders, neurology, orthopaedic diseases, infectious diseases and others. Amongst these, oncology is estimated to be the fastest growing segment during the forecast period. Oncology is one of the world’s fastest-moving therapeutic areas and it is expected to represent a major part of pharmaceutical sales over the future years. Pharmaceutical companies are looking forward to promote their oncology products on large scale in the highly competitive market to obtain prominent share in the overall market.
Region Outlook:
North America accounted for the highest share in the global pharmaceutical contract sales outsourcing (CSO) market in 2020. Companies in the United States have adopted contract sales outsourcing on a very large scale as it has extended across a broad range of commercial operations, including analytics, business intelligence, predicting, market research, sales force efficiency, and marketing services. Pharmaceuticals markets in North America are rapidly evolving and have recently encouraged pharmaceutical companies to broaden the scope of outsourcing across their commercial activities. The endless stream of sources, such as electronic medical records, insurance records, healthcare providers, and social media has led to the emergence and further development of big data, which has aided the growth of North America pharmaceutical contract sales outsourcing (CSO) market.
Competitive Landscape
The report provides both, qualitative and quantitative research of pharmaceutical contract sales outsourcing (CSO) market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
The key market participants operating in the Global Pharmaceutical Contract Sales Outsourcing (CSO) Market are:
- Ascott Sales Integration
- Ashfield (UDG Healthcare PLC)
- CMIC HOLDINGS Co., LTD.
- EPS International Co., Ltd.
- Granard Pharmaceutical Sales and Marketing
- GTS Solution
- IQVIA Inc.
- MaBiCo
- Publicis Touchpoint Solutions
- Sales Partnerships, Inc.
- Syneos Health
- Vanguard Pharma Inc
- Other Market Participants
Global Pharmaceutical Contract Sales Outsourcing (CSO) Market
By Sales Model
- Dedicated Sales Model
- Syndicate Sales Model
By Service Type
- Personal Promotion
- Sales Force Deployment
- Vacancy Management
- Others (Key Account Management, Physician Education Services, Etc.)
- Non-personal Promotion
- Telesales
- Medical Call Centers
- Online Marketing and Sales
- e-Sampling
- Others
- Field Management
- Distribution services
- KOL relationship development program
- Products registration in MOH
- Training and development
- Targeting, Access and Reimbursement
- Others (Recruiting, Sales Training, Etc.)
By Therapeutic Area
- Cardiovascular Disorders
- Oncology
- Covid-19
- Metabolic Disorders
- Neurology
- Orthopedic Diseases
- Infectious Diseases
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
Market Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2019
1.2.2. Base Year: 2020
1.2.3. Forecast Years: 2021 – 2029
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Pharmaceutical Contract Sales Outsourcing (CSO) Market
6.
Market
Synopsis: Pharmaceutical Contract Sales
Outsourcing (CSO) Market
7.
Pharmaceutical
Contract Sales Outsourcing (CSO) Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in Pharmaceutical Contract Sales
Outsourcing (CSO) Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Pharmaceutical Contract Sales Outsourcing (CSO) Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Pharmaceutical Contract
Sales Outsourcing (CSO) Market
8.
Global
Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts,
2021 – 2029
8.1. Overview
8.1.1. Global Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn)
8.2. Global Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
8.2.1. Dedicated Sales Model
8.2.1.1.
Definition
8.2.1.2.
Market
Estimation and Penetration, 2015 - 2020
8.2.1.3.
Market
Forecast, 2021 - 2029
8.2.1.4.
Compound
Annual Growth Rate (CAGR)
8.2.1.5.
Regional
Bifurcation
8.2.1.5.1.
North
America
8.2.1.5.1.1. Market Estimation, 2015 - 2020
8.2.1.5.1.2. Market Forecast, 2021 - 2029
8.2.1.5.2.
Europe
8.2.1.5.2.1. Market Estimation, 2015 - 2020
8.2.1.5.2.2. Market Forecast, 2021 - 2029
8.2.1.5.3.
Asia
Pacific
8.2.1.5.3.1. Market Estimation, 2015 - 2020
8.2.1.5.3.2. Market Forecast, 2021 - 2029
8.2.1.5.4.
Middle
East and Africa
8.2.1.5.4.1. Market Estimation, 2015 - 2020
8.2.1.5.4.2. Market Forecast, 2021 - 2029
8.2.1.5.5.
Latin
America
8.2.1.5.5.1. Market Estimation, 2015 - 2020
8.2.1.5.5.2. Market Forecast, 2021 - 2029
8.2.2. Syndicate Sales Model
8.2.2.1.
Definition
8.2.2.2.
Market
Estimation and Penetration, 2015 - 2020
8.2.2.3.
Market
Forecast, 2021 - 2029
8.2.2.4.
Compound
Annual Growth Rate (CAGR)
8.2.2.5.
Regional
Bifurcation
8.2.2.5.1.
North
America
8.2.2.5.1.1. Market Estimation, 2015 - 2020
8.2.2.5.1.2. Market Forecast, 2021 - 2029
8.2.2.5.2.
Europe
8.2.2.5.2.1. Market Estimation, 2015 - 2020
8.2.2.5.2.2. Market Forecast, 2021 - 2029
8.2.2.5.3.
Asia
Pacific
8.2.2.5.3.1. Market Estimation, 2015 - 2020
8.2.2.5.3.2. Market Forecast, 2021 - 2029
8.2.2.5.4.
Middle
East and Africa
8.2.2.5.4.1. Market Estimation, 2015 - 2020
8.2.2.5.4.2. Market Forecast, 2021 - 2029
8.2.2.5.5.
Latin
America
8.2.2.5.5.1. Market Estimation, 2015 - 2020
8.2.2.5.5.2. Market Forecast, 2021 - 2029
8.3. Key Segment for Channeling Investments
8.3.1. By Sales Model
9.
Global
Pharmaceutical Contract Sales Outsourcing (CSO) Market Analysis and Forecasts,
2021 – 2029
9.1. Overview
9.2. Global Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
9.2.1. Personal Promotion (Definition, Market Estimation and
Penetration, 2015 - 2020, Market Estimation (2015 - 2020), Market Forecast
(2021 - 2029), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Sales Force Deployment, Vacancy Management, Others (Key Account
Management, Physician Education Services, Etc.))
9.2.1.1.
Sales
Force Deployment
9.2.1.2.
Vacancy
Management
9.2.1.3.
Others
(Key Account Management, Physician Education Services, Etc.)
9.2.2. Non-personal Promotion (Definition, Market Estimation and
Penetration, 2015 - 2020, Market Estimation (2015 - 2020), Market Forecast
(2021 - 2029), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Telesales, Medical Call Centers, Online Marketing and Sales,
e-Sampling, Others)
9.2.2.1.
Telesales
9.2.2.2.
Medical
Call Centers
9.2.2.3.
Online
Marketing and Sales
9.2.2.4.
e-Sampling
9.2.2.5.
Others
9.2.3. Field Management
9.2.3.1.
Definition
9.2.3.2.
Market
Estimation and Penetration, 2015 - 2020
9.2.3.3.
Market
Forecast, 2021 - 2029
9.2.3.4.
Compound
Annual Growth Rate (CAGR)
9.2.3.5.
Regional
Bifurcation
9.2.3.5.1.
North
America
9.2.3.5.1.1. Market Estimation, 2015 - 2020
9.2.3.5.1.2. Market Forecast, 2021 - 2029
9.2.3.5.2.
Europe
9.2.3.5.2.1. Market Estimation, 2015 - 2020
9.2.3.5.2.2. Market Forecast, 2021 - 2029
9.2.3.5.3.
Asia
Pacific
9.2.3.5.3.1. Market Estimation, 2015 - 2020
9.2.3.5.3.2. Market Forecast, 2021 - 2029
9.2.3.5.4.
Middle East
and Africa
9.2.3.5.4.1. Market Estimation, 2015 - 2020
9.2.3.5.4.2. Market Forecast, 2021 - 2029
9.2.3.5.5.
Latin
America
9.2.3.5.5.1. Market Estimation, 2015 - 2020
9.2.3.5.5.2. Market Forecast, 2021 - 2029
9.2.4. Distribution services
9.2.4.1.
Definition
9.2.4.2.
Market
Estimation and Penetration, 2015 - 2020
9.2.4.3.
Market
Forecast, 2021 - 2029
9.2.4.4.
Compound
Annual Growth Rate (CAGR)
9.2.4.5.
Regional
Bifurcation
9.2.4.5.1.
North
America
9.2.4.5.1.1. Market Estimation, 2015 - 2020
9.2.4.5.1.2. Market Forecast, 2021 - 2029
9.2.4.5.2.
Europe
9.2.4.5.2.1. Market Estimation, 2015 - 2020
9.2.4.5.2.2. Market Forecast, 2021 - 2029
9.2.4.5.3.
Asia
Pacific
9.2.4.5.3.1. Market Estimation, 2015 - 2020
9.2.4.5.3.2. Market Forecast, 2021 - 2029
9.2.4.5.4.
Middle
East and Africa
9.2.4.5.4.1. Market Estimation, 2015 - 2020
9.2.4.5.4.2. Market Forecast, 2021 - 2029
9.2.4.5.5.
Latin
America
9.2.4.5.5.1. Market Estimation, 2015 - 2020
9.2.4.5.5.2. Market Forecast, 2021 - 2029
9.2.5. Products registration
9.2.5.1.
Definition
9.2.5.2.
Market
Estimation and Penetration, 2015 - 2020
9.2.5.3.
Market
Forecast, 2021 - 2029
9.2.5.4.
Compound
Annual Growth Rate (CAGR)
9.2.5.5.
Regional
Bifurcation
9.2.5.5.1.
North
America
9.2.5.5.1.1. Market Estimation, 2015 - 2020
9.2.5.5.1.2. Market Forecast, 2021 - 2029
9.2.5.5.2.
Europe
9.2.5.5.2.1. Market Estimation, 2015 - 2020
9.2.5.5.2.2. Market Forecast, 2021 - 2029
9.2.5.5.3.
Asia
Pacific
9.2.5.5.3.1. Market Estimation, 2015 - 2020
9.2.5.5.3.2. Market Forecast, 2021 - 2029
9.2.5.5.4.
Middle
East and Africa
9.2.5.5.4.1. Market Estimation, 2015 - 2020
9.2.5.5.4.2. Market Forecast, 2021 - 2029
9.2.5.5.5.
Latin
America
9.2.5.5.5.1. Market Estimation, 2015 - 2020
9.2.5.5.5.2. Market Forecast, 2021 - 2029
9.2.6. Training and development
9.2.6.1.
Definition
9.2.6.2.
Market
Estimation and Penetration, 2015 - 2020
9.2.6.3.
Market
Forecast, 2021 - 2029
9.2.6.4.
Compound
Annual Growth Rate (CAGR)
9.2.6.5.
Regional
Bifurcation
9.2.6.5.1.
North
America
9.2.6.5.1.1. Market Estimation, 2015 - 2020
9.2.6.5.1.2. Market Forecast, 2021 - 2029
9.2.6.5.2.
Europe
9.2.6.5.2.1. Market Estimation, 2015 - 2020
9.2.6.5.2.2. Market Forecast, 2021 - 2029
9.2.6.5.3.
Asia
Pacific
9.2.6.5.3.1. Market Estimation, 2015 - 2020
9.2.6.5.3.2. Market Forecast, 2021 - 2029
9.2.6.5.4.
Middle
East and Africa
9.2.6.5.4.1. Market Estimation, 2015 - 2020
9.2.6.5.4.2. Market Forecast, 2021 - 2029
9.2.6.5.5.
Latin
America
9.2.6.5.5.1. Market Estimation, 2015 - 2020
9.2.6.5.5.2. Market Forecast, 2021 - 2029
9.2.7. Targeting, Access and Reimbursement
9.2.7.1.
Definition
9.2.7.2.
Market
Estimation and Penetration, 2015 - 2020
9.2.7.3.
Market
Forecast, 2021 - 2029
9.2.7.4.
Compound
Annual Growth Rate (CAGR)
9.2.7.5.
Regional
Bifurcation
9.2.7.5.1.
North
America
9.2.7.5.1.1. Market Estimation, 2015 - 2020
9.2.7.5.1.2. Market Forecast, 2021 - 2029
9.2.7.5.2.
Europe
9.2.7.5.2.1. Market Estimation, 2015 - 2020
9.2.7.5.2.2. Market Forecast, 2021 - 2029
9.2.7.5.3.
Asia
Pacific
9.2.7.5.3.1. Market Estimation, 2015 - 2020
9.2.7.5.3.2. Market Forecast, 2021 - 2029
9.2.7.5.4.
Middle
East and Africa
9.2.7.5.4.1. Market Estimation, 2015 - 2020
9.2.7.5.4.2. Market Forecast, 2021 - 2029
9.2.7.5.5.
Latin
America
9.2.7.5.5.1. Market Estimation, 2015 - 2020
9.2.7.5.5.2. Market Forecast, 2021 - 2029
9.2.8. Others (Recruiting, Sales Training, Etc.)
9.2.8.1.
Definition
9.2.8.2.
Market
Estimation and Penetration, 2015 - 2020
9.2.8.3.
Market
Forecast, 2021 - 2029
9.2.8.4.
Compound
Annual Growth Rate (CAGR)
9.2.8.5.
Regional
Bifurcation
9.2.8.5.1.
North
America
9.2.8.5.1.1. Market Estimation, 2015 - 2020
9.2.8.5.1.2. Market Forecast, 2021 - 2029
9.2.8.5.2.
Europe
9.2.8.5.2.1. Market Estimation, 2015 - 2020
9.2.8.5.2.2. Market Forecast, 2021 - 2029
9.2.8.5.3.
Asia
Pacific
9.2.8.5.3.1. Market Estimation, 2015 - 2020
9.2.8.5.3.2. Market Forecast, 2021 - 2029
9.2.8.5.4.
Middle
East and Africa
9.2.8.5.4.1. Market Estimation, 2015 - 2020
9.2.8.5.4.2. Market Forecast, 2021 - 2029
9.2.8.5.5.
Latin
America
9.2.8.5.5.1. Market Estimation, 2015 - 2020
9.2.8.5.5.2. Market Forecast, 2021 - 2029
9.3. Key Segment for Channeling Investments
9.3.1. By Service Type
10. Global Pharmaceutical Contract Sales
Outsourcing (CSO) Market Analysis and Forecasts, 2021 – 2029
10.1. Overview
10.2. Global Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
10.2.1. Cardiovascular Disorders
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 -
2020
10.2.1.3. Market Forecast, 2021 - 2029
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market Estimation, 2015 - 2020
10.2.1.5.1.2. Market Forecast, 2021 - 2029
10.2.1.5.2. Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2020
10.2.1.5.2.2. Market Forecast, 2021 - 2029
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2020
10.2.1.5.3.2. Market Forecast, 2021 - 2029
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2020
10.2.1.5.4.2. Market Forecast, 2021 - 2029
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market Estimation, 2015 - 2020
10.2.1.5.5.2. Market Forecast, 2021 - 2029
10.2.2. Oncology
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 -
2020
10.2.2.3. Market Forecast, 2021 - 2029
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market Estimation, 2015 - 2020
10.2.2.5.1.2. Market Forecast, 2021 - 2029
10.2.2.5.2. Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2020
10.2.2.5.2.2. Market Forecast, 2021 - 2029
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2020
10.2.2.5.3.2. Market Forecast, 2021 - 2029
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2020
10.2.2.5.4.2. Market Forecast, 2021 - 2029
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market Estimation, 2015 - 2020
10.2.2.5.5.2. Market Forecast, 2021 - 2029
10.2.3. Covid-19
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 -
2020
10.2.3.3. Market Forecast, 2021 - 2029
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market Estimation, 2015 - 2020
10.2.3.5.1.2. Market Forecast, 2021 - 2029
10.2.3.5.2. Europe
10.2.3.5.2.1. Market Estimation, 2015 - 2020
10.2.3.5.2.2. Market Forecast, 2021 - 2029
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market Estimation, 2015 - 2020
10.2.3.5.3.2. Market Forecast, 2021 - 2029
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market Estimation, 2015 - 2020
10.2.3.5.4.2. Market Forecast, 2021 - 2029
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market Estimation, 2015 - 2020
10.2.3.5.5.2. Market Forecast, 2021 - 2029
10.2.4. Metabolic Disorders
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 -
2020
10.2.4.3. Market Forecast, 2021 - 2029
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market Estimation, 2015 - 2020
10.2.4.5.1.2. Market Forecast, 2021 - 2029
10.2.4.5.2. Europe
10.2.4.5.2.1. Market Estimation, 2015 - 2020
10.2.4.5.2.2. Market Forecast, 2021 - 2029
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market Estimation, 2015 - 2020
10.2.4.5.3.2. Market Forecast, 2021 - 2029
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market Estimation, 2015 - 2020
10.2.4.5.4.2. Market Forecast, 2021 - 2029
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market Estimation, 2015 - 2020
10.2.4.5.5.2. Market Forecast, 2021 - 2029
10.2.5. Neurology
10.2.5.1. Definition
10.2.5.2. Market Estimation and Penetration, 2015 -
2020
10.2.5.3. Market Forecast, 2021 - 2029
10.2.5.4. Compound Annual Growth Rate (CAGR)
10.2.5.5. Regional Bifurcation
10.2.5.5.1. North America
10.2.5.5.1.1. Market Estimation, 2015 - 2020
10.2.5.5.1.2. Market Forecast, 2021 - 2029
10.2.5.5.2. Europe
10.2.5.5.2.1. Market Estimation, 2015 - 2020
10.2.5.5.2.2. Market Forecast, 2021 - 2029
10.2.5.5.3. Asia Pacific
10.2.5.5.3.1. Market Estimation, 2015 - 2020
10.2.5.5.3.2. Market Forecast, 2021 - 2029
10.2.5.5.4. Middle East and Africa
10.2.5.5.4.1. Market Estimation, 2015 - 2020
10.2.5.5.4.2. Market Forecast, 2021 - 2029
10.2.5.5.5. Latin America
10.2.5.5.5.1. Market Estimation, 2015 - 2020
10.2.5.5.5.2. Market Forecast, 2021 - 2029
10.2.6. Orthopedic Diseases
10.2.6.1. Definition
10.2.6.2. Market Estimation and Penetration, 2015 -
2020
10.2.6.3. Market Forecast, 2021 - 2029
10.2.6.4. Compound Annual Growth Rate (CAGR)
10.2.6.5. Regional Bifurcation
10.2.6.5.1. North America
10.2.6.5.1.1. Market Estimation, 2015 - 2020
10.2.6.5.1.2. Market Forecast, 2021 - 2029
10.2.6.5.2. Europe
10.2.6.5.2.1. Market Estimation, 2015 - 2020
10.2.6.5.2.2. Market Forecast, 2021 - 2029
10.2.6.5.3. Asia Pacific
10.2.6.5.3.1. Market Estimation, 2015 - 2020
10.2.6.5.3.2. Market Forecast, 2021 - 2029
10.2.6.5.4. Middle East and Africa
10.2.6.5.4.1. Market Estimation, 2015 - 2020
10.2.6.5.4.2. Market Forecast, 2021 - 2029
10.2.6.5.5. Latin America
10.2.6.5.5.1. Market Estimation, 2015 - 2020
10.2.6.5.5.2. Market Forecast, 2021 - 2029
10.2.7. Infectious Diseases
10.2.7.1. Definition
10.2.7.2. Market Estimation and Penetration, 2015 -
2020
10.2.7.3. Market Forecast, 2021 - 2029
10.2.7.4. Compound Annual Growth Rate (CAGR)
10.2.7.5. Regional Bifurcation
10.2.7.5.1. North America
10.2.7.5.1.1. Market Estimation, 2015 - 2020
10.2.7.5.1.2. Market Forecast, 2021 - 2029
10.2.7.5.2. Europe
10.2.7.5.2.1. Market Estimation, 2015 - 2020
10.2.7.5.2.2. Market Forecast, 2021 - 2029
10.2.7.5.3. Asia Pacific
10.2.7.5.3.1. Market Estimation, 2015 - 2020
10.2.7.5.3.2. Market Forecast, 2021 - 2029
10.2.7.5.4. Middle East and Africa
10.2.7.5.4.1. Market Estimation, 2015 - 2020
10.2.7.5.4.2. Market Forecast, 2021 - 2029
10.2.7.5.5. Latin America
10.2.7.5.5.1. Market Estimation, 2015 - 2020
10.2.7.5.5.2. Market Forecast, 2021 - 2029
10.2.8. Others
10.2.8.1. Definition
10.2.8.2. Market Estimation and Penetration, 2015 -
2020
10.2.8.3. Market Forecast, 2021 - 2029
10.2.8.4. Compound Annual Growth Rate (CAGR)
10.2.8.5. Regional Bifurcation
10.2.8.5.1. North America
10.2.8.5.1.1. Market Estimation, 2015 - 2020
10.2.8.5.1.2. Market Forecast, 2021 - 2029
10.2.8.5.2. Europe
10.2.8.5.2.1. Market Estimation, 2015 - 2020
10.2.8.5.2.2. Market Forecast, 2021 - 2029
10.2.8.5.3. Asia Pacific
10.2.8.5.3.1. Market Estimation, 2015 - 2020
10.2.8.5.3.2. Market Forecast, 2021 - 2029
10.2.8.5.4. Middle East and Africa
10.2.8.5.4.1. Market Estimation, 2015 - 2020
10.2.8.5.4.2. Market Forecast, 2021 - 2029
10.2.8.5.5. Latin America
10.2.8.5.5.1. Market Estimation, 2015 - 2020
10.2.8.5.5.2. Market Forecast, 2021 - 2029
10.3. Key Segment for Channeling Investments
10.3.1. By Therapeutic Area
11. North America Pharmaceutical Contract Sales
Outsourcing (CSO) Market Analysis and Forecasts, 2021 - 2029
11.1. Overview
11.1.1. North America Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn)
11.2. North America Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
11.2.1. Dedicated Sales Model
11.2.2. Syndicate Sales Model
11.3. North America Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
11.3.1. Personal Promotion
11.3.1.1. Sales Force Deployment
11.3.1.2. Vacancy Management
11.3.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
11.3.2. Non-personal Promotion
11.3.2.1. Telesales
11.3.2.2. Medical Call Centers
11.3.2.3. Online Marketing and Sales
11.3.2.4. e-Sampling
11.3.2.5. Others
11.3.3. Field Management
11.3.4. Distribution services
11.3.5. Products registration
11.3.6. Training and development
11.3.7. Targeting, Access and Reimbursement
11.3.8. Others (Recruiting, Sales Training, Etc.)
11.4. North America Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
11.4.1. Cardiovascular Disorders
11.4.2. Oncology
11.4.3. Covid-19
11.4.4. Metabolic Disorders
11.4.5. Neurology
11.4.6. Orthopedic Diseases
11.4.7. Infectious Diseases
11.4.8. Others
11.5. North America Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Country
11.5.1. U.S
11.5.1.1. U.S Pharmaceutical Contract Sales Outsourcing
(CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
11.5.1.1.1. Dedicated Sales Model
11.5.1.1.2. Syndicate Sales Model
11.5.1.2. U.S Pharmaceutical Contract Sales Outsourcing
(CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
11.5.1.2.1. Personal Promotion
11.5.1.2.1.1. Sales Force Deployment
11.5.1.2.1.2. Vacancy Management
11.5.1.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
11.5.1.2.2. Non-personal Promotion
11.5.1.2.2.1. Telesales
11.5.1.2.2.2. Medical Call Centers
11.5.1.2.2.3. Online Marketing and Sales
11.5.1.2.2.4. e-Sampling
11.5.1.2.2.5. Others
11.5.1.2.3. Field Management
11.5.1.2.4. Distribution services
11.5.1.2.5. Products registration
11.5.1.2.6. Training and development
11.5.1.2.7. Targeting, Access and Reimbursement
11.5.1.2.8. Others (Recruiting, Sales Training, Etc.)
11.5.1.3. U.S Pharmaceutical Contract Sales Outsourcing
(CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
11.5.1.3.1. Cardiovascular Disorders
11.5.1.3.2. Oncology
11.5.1.3.3. Covid-19
11.5.1.3.4. Metabolic Disorders
11.5.1.3.5. Neurology
11.5.1.3.6. Orthopedic Diseases
11.5.1.3.7. Infectious Diseases
11.5.1.3.8. Others
11.5.2. Canada
11.5.2.1. Canada Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
11.5.2.1.1. Dedicated Sales Model
11.5.2.1.2. Syndicate Sales Model
11.5.2.2. Canada Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
11.5.2.2.1. Personal Promotion
11.5.2.2.1.1. Sales Force Deployment
11.5.2.2.1.2. Vacancy Management
11.5.2.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
11.5.2.2.2. Non-personal Promotion
11.5.2.2.2.1. Telesales
11.5.2.2.2.2. Medical Call Centers
11.5.2.2.2.3. Online Marketing and Sales
11.5.2.2.2.4. e-Sampling
11.5.2.2.2.5. Others
11.5.2.2.3. Field Management
11.5.2.2.4. Distribution services
11.5.2.2.5. Products registration
11.5.2.2.6. Training and development
11.5.2.2.7. Targeting, Access and Reimbursement
11.5.2.2.8. Others (Recruiting, Sales Training, Etc.)
11.5.2.3. Canada Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
11.5.2.3.1. Cardiovascular Disorders
11.5.2.3.2. Oncology
11.5.2.3.3. Covid-19
11.5.2.3.4. Metabolic Disorders
11.5.2.3.5. Neurology
11.5.2.3.6. Orthopedic Diseases
11.5.2.3.7. Infectious Diseases
11.5.2.3.8. Others
11.5.3. Mexico
11.5.3.1. Mexico Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
11.5.3.1.1. Dedicated Sales Model
11.5.3.1.2. Syndicate Sales Model
11.5.3.2. Mexico Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
11.5.3.2.1. Personal Promotion
11.5.3.2.1.1. Sales Force Deployment
11.5.3.2.1.2. Vacancy Management
11.5.3.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
11.5.3.2.2. Non-personal Promotion
11.5.3.2.2.1. Telesales
11.5.3.2.2.2. Medical Call Centers
11.5.3.2.2.3. Online Marketing and Sales
11.5.3.2.2.4. e-Sampling
11.5.3.2.2.5. Others
11.5.3.2.3. Field Management
11.5.3.2.4. Distribution services
11.5.3.2.5. Products registration
11.5.3.2.6. Training and development
11.5.3.2.7. Targeting, Access and Reimbursement
11.5.3.2.8. Others (Recruiting, Sales Training, Etc.)
11.5.3.3. Mexico Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
11.5.3.3.1. Cardiovascular Disorders
11.5.3.3.2. Oncology
11.5.3.3.3. Covid-19
11.5.3.3.4. Metabolic Disorders
11.5.3.3.5. Neurology
11.5.3.3.6. Orthopedic Diseases
11.5.3.3.7. Infectious Diseases
11.5.3.3.8. Others
11.5.4. Rest of North America
11.5.4.1. Rest of North America Pharmaceutical Contract
Sales Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
11.5.4.1.1. Dedicated Sales Model
11.5.4.1.2. Syndicate Sales Model
11.5.4.2. Rest of North America Pharmaceutical Contract
Sales Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
11.5.4.2.1. Personal Promotion
11.5.4.2.1.1. Sales Force Deployment
11.5.4.2.1.2. Vacancy Management
11.5.4.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
11.5.4.2.2. Non-personal Promotion
11.5.4.2.2.1. Telesales
11.5.4.2.2.2. Medical Call Centers
11.5.4.2.2.3. Online Marketing and Sales
11.5.4.2.2.4. e-Sampling
11.5.4.2.2.5. Others
11.5.4.2.3. Field Management
11.5.4.2.4. Distribution services
11.5.4.2.5. Products registration
11.5.4.2.6. Training and development
11.5.4.2.7. Targeting, Access and Reimbursement
11.5.4.2.8. Others (Recruiting, Sales Training, Etc.)
11.5.4.3. Rest of North America Pharmaceutical Contract
Sales Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic
Area
11.5.4.3.1. Cardiovascular Disorders
11.5.4.3.2. Oncology
11.5.4.3.3. Covid-19
11.5.4.3.4. Metabolic Disorders
11.5.4.3.5. Neurology
11.5.4.3.6. Orthopedic Diseases
11.5.4.3.7. Infectious Diseases
11.5.4.3.8. Others
11.6. Key Segment for Channeling Investments
11.6.1. By Country
11.6.2. By Sales Model
11.6.3. By Service Type
11.6.4. By Therapeutic Area
12. Europe Pharmaceutical Contract Sales
Outsourcing (CSO) Market Analysis and Forecasts, 2021 - 2029
12.1. Overview
12.1.1. Europe Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn)
12.2. Europe Pharmaceutical Contract Sales Outsourcing
(CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
12.2.1. Dedicated Sales Model
12.2.2. Syndicate Sales Model
12.3. Europe Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
12.3.1. Personal Promotion
12.3.1.1. Sales Force Deployment
12.3.1.2. Vacancy Management
12.3.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
12.3.2. Non-personal Promotion
12.3.2.1. Telesales
12.3.2.2. Medical Call Centers
12.3.2.3. Online Marketing and Sales
12.3.2.4. e-Sampling
12.3.2.5. Others
12.3.3. Field Management
12.3.4. Distribution services
12.3.5. Products registration
12.3.6. Training and development
12.3.7. Targeting, Access and Reimbursement
12.3.8. Others (Recruiting, Sales Training, Etc.)
12.4. Europe Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
12.4.1. Cardiovascular Disorders
12.4.2. Oncology
12.4.3. Covid-19
12.4.4. Metabolic Disorders
12.4.5. Neurology
12.4.6. Orthopedic Diseases
12.4.7. Infectious Diseases
12.4.8. Others
12.5. Europe Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Country
12.5.1. France
12.5.1.1. France Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
12.5.1.1.1. Dedicated Sales Model
12.5.1.1.2. Syndicate Sales Model
12.5.1.2. France Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
12.5.1.2.1. Personal Promotion
12.5.1.2.1.1. Sales Force Deployment
12.5.1.2.1.2. Vacancy Management
12.5.1.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
12.5.1.2.2. Non-personal Promotion
12.5.1.2.2.1. Telesales
12.5.1.2.2.2. Medical Call Centers
12.5.1.2.2.3. Online Marketing and Sales
12.5.1.2.2.4. e-Sampling
12.5.1.2.2.5. Others
12.5.1.2.3. Field Management
12.5.1.2.4. Distribution services
12.5.1.2.5. Products registration
12.5.1.2.6. Training and development
12.5.1.2.7. Targeting, Access and Reimbursement
12.5.1.2.8. Others (Recruiting, Sales Training, Etc.)
12.5.1.3. France Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
12.5.1.3.1. Cardiovascular Disorders
12.5.1.3.2. Oncology
12.5.1.3.3. Covid-19
12.5.1.3.4. Metabolic Disorders
12.5.1.3.5. Neurology
12.5.1.3.6. Orthopedic Diseases
12.5.1.3.7. Infectious Diseases
12.5.1.3.8. Others
12.5.2. The UK
12.5.2.1. The UK Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
12.5.2.1.1. Dedicated Sales Model
12.5.2.1.2. Syndicate Sales Model
12.5.2.2. The UK Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
12.5.2.2.1. Personal Promotion
12.5.2.2.1.1. Sales Force Deployment
12.5.2.2.1.2. Vacancy Management
12.5.2.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
12.5.2.2.2. Non-personal Promotion
12.5.2.2.2.1. Telesales
12.5.2.2.2.2. Medical Call Centers
12.5.2.2.2.3. Online Marketing and Sales
12.5.2.2.2.4. e-Sampling
12.5.2.2.2.5. Others
12.5.2.2.3. Field Management
12.5.2.2.4. Distribution services
12.5.2.2.5. Products registration
12.5.2.2.6. Training and development
12.5.2.2.7. Targeting, Access and Reimbursement
12.5.2.2.8. Others (Recruiting, Sales Training, Etc.)
12.5.2.3. The UK Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
12.5.2.3.1. Cardiovascular Disorders
12.5.2.3.2. Oncology
12.5.2.3.3. Covid-19
12.5.2.3.4. Metabolic Disorders
12.5.2.3.5. Neurology
12.5.2.3.6. Orthopedic Diseases
12.5.2.3.7. Infectious Diseases
12.5.2.3.8. Others
12.5.3. Spain
12.5.3.1. Spain Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
12.5.3.1.1. Dedicated Sales Model
12.5.3.1.2. Syndicate Sales Model
12.5.3.2. Spain Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
12.5.3.2.1. Personal Promotion
12.5.3.2.1.1. Sales Force Deployment
12.5.3.2.1.2. Vacancy Management
12.5.3.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
12.5.3.2.2. Non-personal Promotion
12.5.3.2.2.1. Telesales
12.5.3.2.2.2. Medical Call Centers
12.5.3.2.2.3. Online Marketing and Sales
12.5.3.2.2.4. e-Sampling
12.5.3.2.2.5. Others
12.5.3.2.3. Field Management
12.5.3.2.4. Distribution services
12.5.3.2.5. Products registration
12.5.3.2.6. Training and development
12.5.3.2.7. Targeting, Access and Reimbursement
12.5.3.2.8. Others (Recruiting, Sales Training, Etc.)
12.5.3.3. Spain Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
12.5.3.3.1. Cardiovascular Disorders
12.5.3.3.2. Oncology
12.5.3.3.3. Covid-19
12.5.3.3.4. Metabolic Disorders
12.5.3.3.5. Neurology
12.5.3.3.6. Orthopedic Diseases
12.5.3.3.7. Infectious Diseases
12.5.3.3.8. Others
12.5.4. Germany
12.5.4.1. Germany Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
12.5.4.1.1. Dedicated Sales Model
12.5.4.1.2. Syndicate Sales Model
12.5.4.2. Germany Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
12.5.4.2.1. Personal Promotion
12.5.4.2.1.1. Sales Force Deployment
12.5.4.2.1.2. Vacancy Management
12.5.4.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
12.5.4.2.2. Non-personal Promotion
12.5.4.2.2.1. Telesales
12.5.4.2.2.2. Medical Call Centers
12.5.4.2.2.3. Online Marketing and Sales
12.5.4.2.2.4. e-Sampling
12.5.4.2.2.5. Others
12.5.4.2.3. Field Management
12.5.4.2.4. Distribution services
12.5.4.2.5. Products registration
12.5.4.2.6. Training and development
12.5.4.2.7. Targeting, Access and Reimbursement
12.5.4.2.8. Others (Recruiting, Sales Training, Etc.)
12.5.4.3. Germany Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
12.5.4.3.1. Cardiovascular Disorders
12.5.4.3.2. Oncology
12.5.4.3.3. Covid-19
12.5.4.3.4. Metabolic Disorders
12.5.4.3.5. Neurology
12.5.4.3.6. Orthopedic Diseases
12.5.4.3.7. Infectious Diseases
12.5.4.3.8. Others
12.5.5. Italy
12.5.5.1. Italy Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
12.5.5.1.1. Dedicated Sales Model
12.5.5.1.2. Syndicate Sales Model
12.5.5.2. Italy Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
12.5.5.2.1. Personal Promotion
12.5.5.2.1.1. Sales Force Deployment
12.5.5.2.1.2. Vacancy Management
12.5.5.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
12.5.5.2.2. Non-personal Promotion
12.5.5.2.2.1. Telesales
12.5.5.2.2.2. Medical Call Centers
12.5.5.2.2.3. Online Marketing and Sales
12.5.5.2.2.4. e-Sampling
12.5.5.2.2.5. Others
12.5.5.2.3. Field Management
12.5.5.2.4. Distribution services
12.5.5.2.5. Products registration
12.5.5.2.6. Training and development
12.5.5.2.7. Targeting, Access and Reimbursement
12.5.5.2.8. Others (Recruiting, Sales Training, Etc.)
12.5.5.3. Italy Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
12.5.5.3.1. Cardiovascular Disorders
12.5.5.3.2. Oncology
12.5.5.3.3. Covid-19
12.5.5.3.4. Metabolic Disorders
12.5.5.3.5. Neurology
12.5.5.3.6. Orthopedic Diseases
12.5.5.3.7. Infectious Diseases
12.5.5.3.8. Others
12.5.6. Nordic Countries
12.5.6.1. Nordic Countries Pharmaceutical Contract
Sales Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
12.5.6.1.1. Dedicated Sales Model
12.5.6.1.2. Syndicate Sales Model
12.5.6.2. Nordic Countries Pharmaceutical Contract
Sales Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
12.5.6.2.1. Personal Promotion
12.5.6.2.1.1. Sales Force Deployment
12.5.6.2.1.2. Vacancy Management
12.5.6.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
12.5.6.2.2. Non-personal Promotion
12.5.6.2.2.1. Telesales
12.5.6.2.2.2. Medical Call Centers
12.5.6.2.2.3. Online Marketing and Sales
12.5.6.2.2.4. e-Sampling
12.5.6.2.2.5. Others
12.5.6.2.3. Field Management
12.5.6.2.4. Distribution services
12.5.6.2.5. Products registration
12.5.6.2.6. Training and development
12.5.6.2.7. Targeting, Access and Reimbursement
12.5.6.2.8. Others (Recruiting, Sales Training, Etc.)
12.5.6.3. Nordic Countries Pharmaceutical Contract
Sales Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic
Area
12.5.6.3.1. Cardiovascular Disorders
12.5.6.3.2. Oncology
12.5.6.3.3. Covid-19
12.5.6.3.4. Metabolic Disorders
12.5.6.3.5. Neurology
12.5.6.3.6. Orthopedic Diseases
12.5.6.3.7. Infectious Diseases
12.5.6.3.8. Others
12.5.6.4. Nordic Countries Pharmaceutical Contract
Sales Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux Union
12.5.7.1. Benelux Union Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
12.5.7.1.1. Dedicated Sales Model
12.5.7.1.2. Syndicate Sales Model
12.5.7.2. Benelux Union Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
12.5.7.2.1. Personal Promotion
12.5.7.2.1.1. Sales Force Deployment
12.5.7.2.1.2. Vacancy Management
12.5.7.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
12.5.7.2.2. Non-personal Promotion
12.5.7.2.2.1. Telesales
12.5.7.2.2.2. Medical Call Centers
12.5.7.2.2.3. Online Marketing and Sales
12.5.7.2.2.4. e-Sampling
12.5.7.2.2.5. Others
12.5.7.2.3. Field Management
12.5.7.2.4. Distribution services
12.5.7.2.5. Products registration
12.5.7.2.6. Training and development
12.5.7.2.7. Targeting, Access and Reimbursement
12.5.7.2.8. Others (Recruiting, Sales Training, Etc.)
12.5.7.3. Benelux Union Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
12.5.7.3.1. Cardiovascular Disorders
12.5.7.3.2. Oncology
12.5.7.3.3. Covid-19
12.5.7.3.4. Metabolic Disorders
12.5.7.3.5. Neurology
12.5.7.3.6. Orthopedic Diseases
12.5.7.3.7. Infectious Diseases
12.5.7.3.8. Others
12.5.7.4. Benelux Union Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1. Belgium
12.5.7.4.2. The Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of Europe
12.5.8.1. Rest of Europe Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
12.5.8.1.1. Dedicated Sales Model
12.5.8.1.2. Syndicate Sales Model
12.5.8.2. Rest of Europe Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
12.5.8.2.1. Personal Promotion
12.5.8.2.1.1. Sales Force Deployment
12.5.8.2.1.2. Vacancy Management
12.5.8.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
12.5.8.2.2. Non-personal Promotion
12.5.8.2.2.1. Telesales
12.5.8.2.2.2. Medical Call Centers
12.5.8.2.2.3. Online Marketing and Sales
12.5.8.2.2.4. e-Sampling
12.5.8.2.2.5. Others
12.5.8.2.3. Field Management
12.5.8.2.4. Distribution services
12.5.8.2.5. Products registration
12.5.8.2.6. Training and development
12.5.8.2.7. Targeting, Access and Reimbursement
12.5.8.2.8. Others (Recruiting, Sales Training, Etc.)
12.5.8.3. Rest of Europe Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
12.5.8.3.1. Cardiovascular Disorders
12.5.8.3.2. Oncology
12.5.8.3.3. Covid-19
12.5.8.3.4. Metabolic Disorders
12.5.8.3.5. Neurology
12.5.8.3.6. Orthopedic Diseases
12.5.8.3.7. Infectious Diseases
12.5.8.3.8. Others
12.6. Key Segment for Channeling Investments
12.6.1. By Country
12.6.2. By Sales Model
12.6.3. By Service Type
12.6.4. By Therapeutic Area
13. Asia Pacific Pharmaceutical Contract Sales
Outsourcing (CSO) Market Analysis and Forecasts, 2021 - 2029
13.1. Overview
13.1.1. Asia Pacific Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn)
13.2. Asia Pacific Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
13.2.1. Dedicated Sales Model
13.2.2. Syndicate Sales Model
13.3. Asia Pacific Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
13.3.1. Personal Promotion
13.3.1.1. Sales Force Deployment
13.3.1.2. Vacancy Management
13.3.1.3. Others (Key Account Management, Physician Education
Services, Etc.)
13.3.2. Non-personal Promotion
13.3.2.1. Telesales
13.3.2.2. Medical Call Centers
13.3.2.3. Online Marketing and Sales
13.3.2.4. e-Sampling
13.3.2.5. Others
13.3.3. Field Management
13.3.4. Distribution services
13.3.5. Products registration
13.3.6. Training and development
13.3.7. Targeting, Access and Reimbursement
13.3.8. Others (Recruiting, Sales Training, Etc.)
13.4. Asia Pacific Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
13.4.1. Cardiovascular Disorders
13.4.2. Oncology
13.4.3. Covid-19
13.4.4. Metabolic Disorders
13.4.5. Neurology
13.4.6. Orthopedic Diseases
13.4.7. Infectious Diseases
13.4.8. Others
13.5. Asia Pacific Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Country
13.5.1. China
13.5.1.1. China Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
13.5.1.1.1. Dedicated Sales Model
13.5.1.1.2. Syndicate Sales Model
13.5.1.2. China Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
13.5.1.2.1. Personal Promotion
13.5.1.2.1.1. Sales Force Deployment
13.5.1.2.1.2. Vacancy Management
13.5.1.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
13.5.1.2.2. Non-personal Promotion
13.5.1.2.2.1. Telesales
13.5.1.2.2.2. Medical Call Centers
13.5.1.2.2.3. Online Marketing and Sales
13.5.1.2.2.4. e-Sampling
13.5.1.2.2.5. Others
13.5.1.2.3. Field Management
13.5.1.2.4. Distribution services
13.5.1.2.5. Products registration
13.5.1.2.6. Training and development
13.5.1.2.7. Targeting, Access and Reimbursement
13.5.1.2.8. Others (Recruiting, Sales Training, Etc.)
13.5.1.3. China Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
13.5.1.3.1. Cardiovascular Disorders
13.5.1.3.2. Oncology
13.5.1.3.3. Covid-19
13.5.1.3.4. Metabolic Disorders
13.5.1.3.5. Neurology
13.5.1.3.6. Orthopedic Diseases
13.5.1.3.7. Infectious Diseases
13.5.1.3.8. Others
13.5.2. Japan
13.5.2.1. Japan Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
13.5.2.1.1. Dedicated Sales Model
13.5.2.1.2. Syndicate Sales Model
13.5.2.2. Japan Pharmaceutical Contract Sales Outsourcing
(CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
13.5.2.2.1. Personal Promotion
13.5.2.2.1.1. Sales Force Deployment
13.5.2.2.1.2. Vacancy Management
13.5.2.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
13.5.2.2.2. Non-personal Promotion
13.5.2.2.2.1. Telesales
13.5.2.2.2.2. Medical Call Centers
13.5.2.2.2.3. Online Marketing and Sales
13.5.2.2.2.4. e-Sampling
13.5.2.2.2.5. Others
13.5.2.2.3. Field Management
13.5.2.2.4. Distribution services
13.5.2.2.5. Products registration
13.5.2.2.6. Training and development
13.5.2.2.7. Targeting, Access and Reimbursement
13.5.2.2.8. Others (Recruiting, Sales Training, Etc.)
13.5.2.3. Japan Pharmaceutical Contract Sales Outsourcing
(CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
13.5.2.3.1. Cardiovascular Disorders
13.5.2.3.2. Oncology
13.5.2.3.3. Covid-19
13.5.2.3.4. Metabolic Disorders
13.5.2.3.5. Neurology
13.5.2.3.6. Orthopedic Diseases
13.5.2.3.7. Infectious Diseases
13.5.2.3.8. Others
13.5.3. India
13.5.3.1. India Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
13.5.3.1.1. Dedicated Sales Model
13.5.3.1.2. Syndicate Sales Model
13.5.3.2. India Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
13.5.3.2.1. Personal Promotion
13.5.3.2.1.1. Sales Force Deployment
13.5.3.2.1.2. Vacancy Management
13.5.3.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
13.5.3.2.2. Non-personal Promotion
13.5.3.2.2.1. Telesales
13.5.3.2.2.2. Medical Call Centers
13.5.3.2.2.3. Online Marketing and Sales
13.5.3.2.2.4. e-Sampling
13.5.3.2.2.5. Others
13.5.3.2.3. Field Management
13.5.3.2.4. Distribution services
13.5.3.2.5. Products registration
13.5.3.2.6. Training and development
13.5.3.2.7. Targeting, Access and Reimbursement
13.5.3.2.8. Others (Recruiting, Sales Training, Etc.)
13.5.3.3. India Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
13.5.3.3.1. Cardiovascular Disorders
13.5.3.3.2. Oncology
13.5.3.3.3. Covid-19
13.5.3.3.4. Metabolic Disorders
13.5.3.3.5. Neurology
13.5.3.3.6. Orthopedic Diseases
13.5.3.3.7. Infectious Diseases
13.5.3.3.8. Others
13.5.4. New Zealand
13.5.4.1. New Zealand Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
13.5.4.1.1. Dedicated Sales Model
13.5.4.1.2. Syndicate Sales Model
13.5.4.2. New Zealand Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
13.5.4.2.1. Personal Promotion
13.5.4.2.1.1. Sales Force Deployment
13.5.4.2.1.2. Vacancy Management
13.5.4.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
13.5.4.2.2. Non-personal Promotion
13.5.4.2.2.1. Telesales
13.5.4.2.2.2. Medical Call Centers
13.5.4.2.2.3. Online Marketing and Sales
13.5.4.2.2.4. e-Sampling
13.5.4.2.2.5. Others
13.5.4.2.3. Field Management
13.5.4.2.4. Distribution services
13.5.4.2.5. Products registration
13.5.4.2.6. Training and development
13.5.4.2.7. Targeting, Access and Reimbursement
13.5.4.2.8. Others (Recruiting, Sales Training, Etc.)
13.5.4.3. New Zealand Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
13.5.4.3.1. Cardiovascular Disorders
13.5.4.3.2. Oncology
13.5.4.3.3. Covid-19
13.5.4.3.4. Metabolic Disorders
13.5.4.3.5. Neurology
13.5.4.3.6. Orthopedic Diseases
13.5.4.3.7. Infectious Diseases
13.5.4.3.8. Others
13.5.5. Australia
13.5.5.1. Australia Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
13.5.5.1.1. Dedicated Sales Model
13.5.5.1.2. Syndicate Sales Model
13.5.5.2. Australia Pharmaceutical Contract Sales Outsourcing
(CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
13.5.5.2.1. Personal Promotion
13.5.5.2.1.1. Sales Force Deployment
13.5.5.2.1.2. Vacancy Management
13.5.5.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
13.5.5.2.2. Non-personal Promotion
13.5.5.2.2.1. Telesales
13.5.5.2.2.2. Medical Call Centers
13.5.5.2.2.3. Online Marketing and Sales
13.5.5.2.2.4. e-Sampling
13.5.5.2.2.5. Others
13.5.5.2.3. Field Management
13.5.5.2.4. Distribution services
13.5.5.2.5. Products registration
13.5.5.2.6. Training and development
13.5.5.2.7. Targeting, Access and Reimbursement
13.5.5.2.8. Others (Recruiting, Sales Training, Etc.)
13.5.5.3. Australia Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
13.5.5.3.1. Cardiovascular Disorders
13.5.5.3.2. Oncology
13.5.5.3.3. Covid-19
13.5.5.3.4. Metabolic Disorders
13.5.5.3.5. Neurology
13.5.5.3.6. Orthopedic Diseases
13.5.5.3.7. Infectious Diseases
13.5.5.3.8. Others
13.5.6. South Korea
13.5.6.1. South Korea Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
13.5.6.1.1. Dedicated Sales Model
13.5.6.1.2. Syndicate Sales Model
13.5.6.2. South Korea Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
13.5.6.2.1. Personal Promotion
13.5.6.2.1.1. Sales Force Deployment
13.5.6.2.1.2. Vacancy Management
13.5.6.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
13.5.6.2.2. Non-personal Promotion
13.5.6.2.2.1. Telesales
13.5.6.2.2.2. Medical Call Centers
13.5.6.2.2.3. Online Marketing and Sales
13.5.6.2.2.4. e-Sampling
13.5.6.2.2.5. Others
13.5.6.2.3. Field Management
13.5.6.2.4. Distribution services
13.5.6.2.5. Products registration
13.5.6.2.6. Training and development
13.5.6.2.7. Targeting, Access and Reimbursement
13.5.6.2.8. Others (Recruiting, Sales Training, Etc.)
13.5.6.3. South Korea Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
13.5.6.3.1. Cardiovascular Disorders
13.5.6.3.2. Oncology
13.5.6.3.3. Covid-19
13.5.6.3.4. Metabolic Disorders
13.5.6.3.5. Neurology
13.5.6.3.6. Orthopedic Diseases
13.5.6.3.7. Infectious Diseases
13.5.6.3.8. Others
13.5.7. Southeast Asia
13.5.7.1. Southeast Asia Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
13.5.7.1.1. Dedicated Sales Model
13.5.7.1.2. Syndicate Sales Model
13.5.7.2. Southeast Asia Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
13.5.7.2.1. Personal Promotion
13.5.7.2.1.1. Sales Force Deployment
13.5.7.2.1.2. Vacancy Management
13.5.7.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
13.5.7.2.2. Non-personal Promotion
13.5.7.2.2.1. Telesales
13.5.7.2.2.2. Medical Call Centers
13.5.7.2.2.3. Online Marketing and Sales
13.5.7.2.2.4. e-Sampling
13.5.7.2.2.5. Others
13.5.7.2.3. Field Management
13.5.7.2.4. Distribution services
13.5.7.2.5. Products registration
13.5.7.2.6. Training and development
13.5.7.2.7. Targeting, Access and Reimbursement
13.5.7.2.8. Others (Recruiting, Sales Training, Etc.)
13.5.7.3. Southeast Asia Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
13.5.7.3.1. Cardiovascular Disorders
13.5.7.3.2. Oncology
13.5.7.3.3. Covid-19
13.5.7.3.4. Metabolic Disorders
13.5.7.3.5. Neurology
13.5.7.3.6. Orthopedic Diseases
13.5.7.3.7. Infectious Diseases
13.5.7.3.8. Others
13.5.7.4. Southeast Asia Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest of Southeast Asia
13.5.8. Rest of Asia Pacific
13.5.8.1. Rest of Asia Pacific Pharmaceutical Contract
Sales Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
13.5.8.1.1. Dedicated Sales Model
13.5.8.1.2. Syndicate Sales Model
13.5.8.2. Rest of Asia Pacific Pharmaceutical Contract
Sales Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
13.5.8.2.1. Personal Promotion
13.5.8.2.1.1. Sales Force Deployment
13.5.8.2.1.2. Vacancy Management
13.5.8.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
13.5.8.2.2. Non-personal Promotion
13.5.8.2.2.1. Telesales
13.5.8.2.2.2. Medical Call Centers
13.5.8.2.2.3. Online Marketing and Sales
13.5.8.2.2.4. e-Sampling
13.5.8.2.2.5. Others
13.5.8.2.3. Field Management
13.5.8.2.4. Distribution services
13.5.8.2.5. Products registration
13.5.8.2.6. Training and development
13.5.8.2.7. Targeting, Access and Reimbursement
13.5.8.2.8. Others (Recruiting, Sales Training, Etc.)
13.5.8.3. Rest of Asia Pacific Pharmaceutical Contract
Sales Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic
Area
13.5.8.3.1. Cardiovascular Disorders
13.5.8.3.2. Oncology
13.5.8.3.3. Covid-19
13.5.8.3.4. Metabolic Disorders
13.5.8.3.5. Neurology
13.5.8.3.6. Orthopedic Diseases
13.5.8.3.7. Infectious Diseases
13.5.8.3.8. Others
13.6. Key Segment for Channeling Investments
13.6.1. By Country
13.6.2. By Sales Model
13.6.3. By Service Type
13.6.4. By Therapeutic Area
14. Middle East and Africa Pharmaceutical
Contract Sales Outsourcing (CSO) Market Analysis and Forecasts, 2021 - 2029
14.1. Overview
14.1.1. Middle East and Africa Pharmaceutical
Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn)
14.2. Middle East and Africa Pharmaceutical
Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By
Sales Model
14.2.1. Dedicated Sales Model
14.2.2. Syndicate Sales Model
14.3. Middle East and Africa Pharmaceutical
Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By
Service Type
14.3.1. Personal Promotion
14.3.1.1. Sales Force Deployment
14.3.1.2. Vacancy Management
14.3.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
14.3.2. Non-personal Promotion
14.3.2.1. Telesales
14.3.2.2. Medical Call Centers
14.3.2.3. Online Marketing and Sales
14.3.2.4. e-Sampling
14.3.2.5. Others
14.3.3. Field Management
14.3.4. Distribution services
14.3.5. Products registration
14.3.6. Training and development
14.3.7. Targeting, Access and Reimbursement
14.3.8. Others (Recruiting, Sales Training, Etc.)
14.4. Middle East and Africa Pharmaceutical
Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By
Therapeutic Area
14.4.1. Cardiovascular Disorders
14.4.2. Oncology
14.4.3. Covid-19
14.4.4. Metabolic Disorders
14.4.5. Neurology
14.4.6. Orthopedic Diseases
14.4.7. Infectious Diseases
14.4.8. Others
14.5. Middle East and Africa Pharmaceutical
Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By
Country
14.5.1. Saudi Arabia
14.5.1.1. Saudi Arabia Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
14.5.1.1.1. Dedicated Sales Model
14.5.1.1.2. Syndicate Sales Model
14.5.1.2. Saudi Arabia Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
14.5.1.2.1. Personal Promotion
14.5.1.2.1.1. Sales Force Deployment
14.5.1.2.1.2. Vacancy Management
14.5.1.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
14.5.1.2.2. Non-personal Promotion
14.5.1.2.2.1. Telesales
14.5.1.2.2.2. Medical Call Centers
14.5.1.2.2.3. Online Marketing and Sales
14.5.1.2.2.4. e-Sampling
14.5.1.2.2.5. Others
14.5.1.2.3. Field Management
14.5.1.2.4. Distribution services
14.5.1.2.5. Products registration
14.5.1.2.6. Training and development
14.5.1.2.7. Targeting, Access and Reimbursement
14.5.1.2.8. Others (Recruiting, Sales Training, Etc.)
14.5.1.3. Saudi Arabia Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
14.5.1.3.1. Cardiovascular Disorders
14.5.1.3.2. Oncology
14.5.1.3.3. Covid-19
14.5.1.3.4. Metabolic Disorders
14.5.1.3.5. Neurology
14.5.1.3.6. Orthopedic Diseases
14.5.1.3.7. Infectious Diseases
14.5.1.3.8. Others
14.5.2. UAE
14.5.2.1. UAE Pharmaceutical Contract Sales Outsourcing
(CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
14.5.2.1.1. Dedicated Sales Model
14.5.2.1.2. Syndicate Sales Model
14.5.2.2. UAE Pharmaceutical Contract Sales Outsourcing
(CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
14.5.2.2.1. Personal Promotion
14.5.2.2.1.1. Sales Force Deployment
14.5.2.2.1.2. Vacancy Management
14.5.2.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
14.5.2.2.2. Non-personal Promotion
14.5.2.2.2.1. Telesales
14.5.2.2.2.2. Medical Call Centers
14.5.2.2.2.3. Online Marketing and Sales
14.5.2.2.2.4. e-Sampling
14.5.2.2.2.5. Others
14.5.2.2.3. Field Management
14.5.2.2.4. Distribution services
14.5.2.2.5. Products registration
14.5.2.2.6. Training and development
14.5.2.2.7. Targeting, Access and Reimbursement
14.5.2.2.8. Others (Recruiting, Sales Training, Etc.)
14.5.2.3. UAE Pharmaceutical Contract Sales Outsourcing
(CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
14.5.2.3.1. Cardiovascular Disorders
14.5.2.3.2. Oncology
14.5.2.3.3. Covid-19
14.5.2.3.4. Metabolic Disorders
14.5.2.3.5. Neurology
14.5.2.3.6. Orthopedic Diseases
14.5.2.3.7. Infectious Diseases
14.5.2.3.8. Others
14.5.3. Egypt
14.5.3.1. Egypt Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
14.5.3.1.1. Dedicated Sales Model
14.5.3.1.2. Syndicate Sales Model
14.5.3.2. Egypt Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
14.5.3.2.1. Personal Promotion
14.5.3.2.1.1. Sales Force Deployment
14.5.3.2.1.2. Vacancy Management
14.5.3.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
14.5.3.2.2. Non-personal Promotion
14.5.3.2.2.1. Telesales
14.5.3.2.2.2. Medical Call Centers
14.5.3.2.2.3. Online Marketing and Sales
14.5.3.2.2.4. e-Sampling
14.5.3.2.2.5. Others
14.5.3.2.3. Field Management
14.5.3.2.4. Distribution services
14.5.3.2.5. Products registration
14.5.3.2.6. Training and development
14.5.3.2.7. Targeting, Access and Reimbursement
14.5.3.2.8. Others (Recruiting, Sales Training, Etc.)
14.5.3.3. Egypt Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
14.5.3.3.1. Cardiovascular Disorders
14.5.3.3.2. Oncology
14.5.3.3.3. Covid-19
14.5.3.3.4. Metabolic Disorders
14.5.3.3.5. Neurology
14.5.3.3.6. Orthopedic Diseases
14.5.3.3.7. Infectious Diseases
14.5.3.3.8. Others
14.5.4. Kuwait
14.5.4.1. Kuwait Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
14.5.4.1.1. Dedicated Sales Model
14.5.4.1.2. Syndicate Sales Model
14.5.4.2. Kuwait Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
14.5.4.2.1. Personal Promotion
14.5.4.2.1.1. Sales Force Deployment
14.5.4.2.1.2. Vacancy Management
14.5.4.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
14.5.4.2.2. Non-personal Promotion
14.5.4.2.2.1. Telesales
14.5.4.2.2.2. Medical Call Centers
14.5.4.2.2.3. Online Marketing and Sales
14.5.4.2.2.4. e-Sampling
14.5.4.2.2.5. Others
14.5.4.2.3. Field Management
14.5.4.2.4. Distribution services
14.5.4.2.5. Products registration
14.5.4.2.6. Training and development
14.5.4.2.7. Targeting, Access and Reimbursement
14.5.4.2.8. Others (Recruiting, Sales Training, Etc.)
14.5.4.3. Kuwait Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
14.5.4.3.1. Cardiovascular Disorders
14.5.4.3.2. Oncology
14.5.4.3.3. Covid-19
14.5.4.3.4. Metabolic Disorders
14.5.4.3.5. Neurology
14.5.4.3.6. Orthopedic Diseases
14.5.4.3.7. Infectious Diseases
14.5.4.3.8. Others
14.5.5. South Africa
14.5.5.1. South Africa Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
14.5.5.1.1. Dedicated Sales Model
14.5.5.1.2. Syndicate Sales Model
14.5.5.2. South Africa Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
14.5.5.2.1. Personal Promotion
14.5.5.2.1.1. Sales Force Deployment
14.5.5.2.1.2. Vacancy Management
14.5.5.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
14.5.5.2.2. Non-personal Promotion
14.5.5.2.2.1. Telesales
14.5.5.2.2.2. Medical Call Centers
14.5.5.2.2.3. Online Marketing and Sales
14.5.5.2.2.4. e-Sampling
14.5.5.2.2.5. Others
14.5.5.2.3. Field Management
14.5.5.2.4. Distribution services
14.5.5.2.5. Products registration
14.5.5.2.6. Training and development
14.5.5.2.7. Targeting, Access and Reimbursement
14.5.5.2.8. Others (Recruiting, Sales Training, Etc.)
14.5.5.3. South Africa Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
14.5.5.3.1. Cardiovascular Disorders
14.5.5.3.2. Oncology
14.5.5.3.3. Covid-19
14.5.5.3.4. Metabolic Disorders
14.5.5.3.5. Neurology
14.5.5.3.6. Orthopedic Diseases
14.5.5.3.7. Infectious Diseases
14.5.5.3.8. Others
14.5.6. Rest of Middle East & Africa
14.5.6.1. Rest of Middle East & Africa
Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn) and
Forecasts, By Sales Model
14.5.6.1.1. Dedicated Sales Model
14.5.6.1.2. Syndicate Sales Model
14.5.6.2. Rest of Middle East & Africa
Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn) and
Forecasts, By Service Type
14.5.6.2.1. Personal Promotion
14.5.6.2.1.1. Sales Force Deployment
14.5.6.2.1.2. Vacancy Management
14.5.6.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
14.5.6.2.2. Non-personal Promotion
14.5.6.2.2.1. Telesales
14.5.6.2.2.2. Medical Call Centers
14.5.6.2.2.3. Online Marketing and Sales
14.5.6.2.2.4. e-Sampling
14.5.6.2.2.5. Others
14.5.6.2.3. Field Management
14.5.6.2.4. Distribution services
14.5.6.2.5. Products registration
14.5.6.2.6. Training and development
14.5.6.2.7. Targeting, Access and Reimbursement
14.5.6.2.8. Others (Recruiting, Sales Training, Etc.)
14.5.6.3. Rest of Middle East & Africa
Pharmaceutical Contract Sales Outsourcing (CSO) Market Revenue (US$ Mn) and
Forecasts, By Therapeutic Area
14.5.6.3.1. Cardiovascular Disorders
14.5.6.3.2. Oncology
14.5.6.3.3. Covid-19
14.5.6.3.4. Metabolic Disorders
14.5.6.3.5. Neurology
14.5.6.3.6. Orthopedic Diseases
14.5.6.3.7. Infectious Diseases
14.5.6.3.8. Others
14.6. Key Segment for Channeling Investments
14.6.1. By Country
14.6.2. By Sales Model
14.6.3. By Service Type
14.6.4. By Therapeutic Area
15. Latin America Pharmaceutical Contract Sales
Outsourcing (CSO) Market Analysis and Forecasts, 2021 - 2029
15.1. Overview
15.1.1. Latin America Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn)
15.2. Latin America Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
15.2.1. Dedicated Sales Model
15.2.2. Syndicate Sales Model
15.3. Latin America Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
15.3.1. Personal Promotion
15.3.1.1. Sales Force Deployment
15.3.1.2. Vacancy Management
15.3.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
15.3.2. Non-personal Promotion
15.3.2.1. Telesales
15.3.2.2. Medical Call Centers
15.3.2.3. Online Marketing and Sales
15.3.2.4. e-Sampling
15.3.2.5. Others
15.3.3. Field Management
15.3.4. Distribution services
15.3.5. Products registration
15.3.6. Training and development
15.3.7. Targeting, Access and Reimbursement
15.3.8. Others (Recruiting, Sales Training, Etc.)
15.4. Latin America Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
15.4.1. Cardiovascular Disorders
15.4.2. Oncology
15.4.3. Covid-19
15.4.4. Metabolic Disorders
15.4.5. Neurology
15.4.6. Orthopedic Diseases
15.4.7. Infectious Diseases
15.4.8. Others
15.5. Latin America Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Country
15.5.1. Brazil
15.5.1.1. Brazil Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
15.5.1.1.1. Dedicated Sales Model
15.5.1.1.2. Syndicate Sales Model
15.5.1.2. Brazil Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
15.5.1.2.1. Personal Promotion
15.5.1.2.1.1. Sales Force Deployment
15.5.1.2.1.2. Vacancy Management
15.5.1.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
15.5.1.2.2. Non-personal Promotion
15.5.1.2.2.1. Telesales
15.5.1.2.2.2. Medical Call Centers
15.5.1.2.2.3. Online Marketing and Sales
15.5.1.2.2.4. e-Sampling
15.5.1.2.2.5. Others
15.5.1.2.3. Field Management
15.5.1.2.4. Distribution services
15.5.1.2.5. Products registration
15.5.1.2.6. Training and development
15.5.1.2.7. Targeting, Access and Reimbursement
15.5.1.2.8. Others (Recruiting, Sales Training, Etc.)
15.5.1.3. Brazil Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
15.5.1.3.1. Cardiovascular Disorders
15.5.1.3.2. Oncology
15.5.1.3.3. Covid-19
15.5.1.3.4. Metabolic Disorders
15.5.1.3.5. Neurology
15.5.1.3.6. Orthopedic Diseases
15.5.1.3.7. Infectious Diseases
15.5.1.3.8. Others
15.5.2. Argentina
15.5.2.1. Argentina Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
15.5.2.1.1. Dedicated Sales Model
15.5.2.1.2. Syndicate Sales Model
15.5.2.2. Argentina Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
15.5.2.2.1. Personal Promotion
15.5.2.2.1.1. Sales Force Deployment
15.5.2.2.1.2. Vacancy Management
15.5.2.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
15.5.2.2.2. Non-personal Promotion
15.5.2.2.2.1. Telesales
15.5.2.2.2.2. Medical Call Centers
15.5.2.2.2.3. Online Marketing and Sales
15.5.2.2.2.4. e-Sampling
15.5.2.2.2.5. Others
15.5.2.2.3. Field Management
15.5.2.2.4. Distribution services
15.5.2.2.5. Products registration
15.5.2.2.6. Training and development
15.5.2.2.7. Targeting, Access and Reimbursement
15.5.2.2.8. Others (Recruiting, Sales Training, Etc.)
15.5.2.3. Argentina Pharmaceutical Contract Sales
Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic Area
15.5.2.3.1. Cardiovascular Disorders
15.5.2.3.2. Oncology
15.5.2.3.3. Covid-19
15.5.2.3.4. Metabolic Disorders
15.5.2.3.5. Neurology
15.5.2.3.6. Orthopedic Diseases
15.5.2.3.7. Infectious Diseases
15.5.2.3.8. Others
15.5.3. Rest of Latin America
15.5.3.1. Rest of Latin America Pharmaceutical Contract
Sales Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Sales Model
15.5.3.1.1. Dedicated Sales Model
15.5.3.1.2. Syndicate Sales Model
15.5.3.2. Rest of Latin America Pharmaceutical Contract
Sales Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Service Type
15.5.3.2.1. Personal Promotion
15.5.3.2.1.1. Sales Force Deployment
15.5.3.2.1.2. Vacancy Management
15.5.3.2.1.3. Others (Key Account Management, Physician
Education Services, Etc.)
15.5.3.2.2. Non-personal Promotion
15.5.3.2.2.1. Telesales
15.5.3.2.2.2. Medical Call Centers
15.5.3.2.2.3. Online Marketing and Sales
15.5.3.2.2.4. e-Sampling
15.5.3.2.2.5. Others
15.5.3.2.3. Field Management
15.5.3.2.4. Distribution services
15.5.3.2.5. Products registration
15.5.3.2.6. Training and development
15.5.3.2.7. Targeting, Access and Reimbursement
15.5.3.2.8. Others (Recruiting, Sales Training, Etc.)
15.5.3.3. Rest of Latin America Pharmaceutical Contract
Sales Outsourcing (CSO) Market Revenue (US$ Mn) and Forecasts, By Therapeutic
Area
15.5.3.3.1. Cardiovascular Disorders
15.5.3.3.2. Oncology
15.5.3.3.3. Covid-19
15.5.3.3.4. Metabolic Disorders
15.5.3.3.5. Neurology
15.5.3.3.6. Orthopedic Diseases
15.5.3.3.7. Infectious Diseases
15.5.3.3.8. Others
15.6. Key Segment for Channeling Investments
15.6.1. By Country
15.6.2. By Sales Model
15.6.3. By Service Type
15.6.4. By Therapeutic Area
16. Competitive Benchmarking
16.1. Market Share Analysis, 2020
16.2. Global Presence and Growth Strategies
16.2.1. Mergers and Acquisitions
16.2.2. Product Launches
16.2.3. Investments Trends
16.2.4. R&D Initiatives
17. Player Profiles
17.1. Ascott Sales Integration
17.1.1. Company Details
17.1.2. Company Overview
17.1.3. Product Offerings
17.1.4. Key Developments
17.1.5. Financial Analysis
17.1.6. SWOT Analysis
17.1.7. Business Strategies
17.2. Ashfield (UDG Healthcare PLC)
17.2.1. Company Details
17.2.2. Company Overview
17.2.3. Product Offerings
17.2.4. Key Developments
17.2.5. Financial Analysis
17.2.6. SWOT Analysis
17.2.7. Business Strategies
17.3. CMIC HOLDINGS Co., LTD.
17.3.1. Company Details
17.3.2. Company Overview
17.3.3. Product Offerings
17.3.4. Key Developments
17.3.5. Financial Analysis
17.3.6. SWOT Analysis
17.3.7. Business Strategies
17.4. EPS International Co., Ltd.
17.4.1. Company Details
17.4.2. Company Overview
17.4.3. Product Offerings
17.4.4. Key Developments
17.4.5. Financial Analysis
17.4.6. SWOT Analysis
17.4.7. Business Strategies
17.5. Granard Pharmaceutical Sales and Marketing
17.5.1. Company Details
17.5.2. Company Overview
17.5.3. Product Offerings
17.5.4. Key Developments
17.5.5. Financial Analysis
17.5.6. SWOT Analysis
17.5.7. Business Strategies
17.6. GTS Solution
17.6.1. Company Details
17.6.2. Company Overview
17.6.3. Product Offerings
17.6.4. Key Developments
17.6.5. Financial Analysis
17.6.6. SWOT Analysis
17.6.7. Business Strategies
17.7. IQVIA Inc.
17.7.1. Company Details
17.7.2. Company Overview
17.7.3. Product Offerings
17.7.4. Key Developments
17.7.5. Financial Analysis
17.7.6. SWOT Analysis
17.7.7. Business Strategies
17.8. MaBiCo
17.8.1. Company Details
17.8.2. Company Overview
17.8.3. Product Offerings
17.8.4. Key Developments
17.8.5. Financial Analysis
17.8.6. SWOT Analysis
17.8.7. Business Strategies
17.9. Mednext Pharma Private Limited
17.9.1. Company Details
17.9.2. Company Overview
17.9.3. Product Offerings
17.9.4. Key Developments
17.9.5. Financial Analysis
17.9.6. SWOT Analysis
17.9.7. Business Strategies
17.10. Publicis Touchpoint Solutions
17.10.1. Company Details
17.10.2. Company Overview
17.10.3. Product Offerings
17.10.4. Key Developments
17.10.5. Financial Analysis
17.10.6. SWOT Analysis
17.10.7. Business Strategies
17.11. Sales Partnerships, Inc.
17.11.1. Company Details
17.11.2. Company Overview
17.11.3. Product Offerings
17.11.4. Key Developments
17.11.5. Financial Analysis
17.11.6. SWOT Analysis
17.11.7. Business Strategies
17.12. Syneos Health
17.12.1. Company Details
17.12.2. Company Overview
17.12.3. Product Offerings
17.12.4. Key Developments
17.12.5. Financial Analysis
17.12.6. SWOT Analysis
17.12.7. Business Strategies
17.13. Vanguard Pharma Inc
17.13.1. Company Details
17.13.2. Company Overview
17.13.3. Product Offerings
17.13.4. Key Developments
17.13.5. Financial Analysis
17.13.6. SWOT Analysis
17.13.7. Business Strategies
17.14. Other Market Participants
18.
Key
Findings
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.